🔎 Trials Near Me

Home › COPD › NCT05399056

Improving Participation in Pulmonary Rehabilitation Through Peer Support and Storytelling

Recruiting

Who can join

Ages 40 and older · All sexes

Full eligibility criteria
Inclusion Criteria:

* 40 years or older
* Received treatment for COPD exacerbation in either inpatient or outpatient setting
* Referred for pulmonary rehabilitation
* Ability to understand and communicate in English
* Willingness to participate in calls with peer coach and to view storytelling videos
* Working phone

Exclusion Criteria:

* Unwilling to attend PR
* Not eligible for PR based on spirometry or other clinical contraindications as determined by PR staff
* Currently enrolled in, or completion of 12 or more sessions of PR in the past
* Comfort measures only or Hospice care
* Resident of long-term care facility
* Unable or unwilling to give informed consent

About the study

Chronic Obstructive Pulmonary Disease (COPD) affects approximately 16 million Americans and is characterized by recurrent exacerbations that lead to 1.5 million Emergency Department visits and 700,000 hospitalizations annually. Pulmonary rehabilitation (PR) is a structured program of exercise and self-management support that has been proven to relieve shortness of breath and increase quality of life when initiated after an exacerbation, but unfortunately, few eligible patients participate. This project will compare the effectiveness of two novel strategies - one involving video narratives of other patients telling their story of how they overcame challenges and completed PR, the other involving telephonic peer coaching with an individual with lived experience - to enhanced usual care, and to each other, at increasing patient participation in PR after an exacerbation.

What is being tested

Sponsor: Baystate Medical Center · Participants: 305 · Started: Feb 24, 2023

Contact the study team

Official record on ClinicalTrials.gov — NCT05399056

Locations in the U.S.

MassachusettsBaystate Health, Springfield

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.